stella
beta
Multi-modal Characterisation of Hepatocellular Carcinoma (HCC) Treated With Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National Cohort — Stella
Home
/
Hepatocellular Carcinoma
/
Multi-modal Characterisation of Hepatocellular Carcinoma (HCC) Treated With Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National Cohort
View on ClinicalTrials.gov
Recruiting
Back to Hepatocellular Carcinoma trials
Multi-modal Characterisation of Hepatocellular Carcinoma (HCC) Treated With Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National Cohort
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(5 sites)
France
Service de Médecine Nucléaire, Hôpital Beaujon, Clichy
Beaujon hospital, Clichy
CHU Nantes, Nantes
Service de Médecine Nucléaire, CHU de Nantes, Nantes
Service de medecine nucleaire, Hôpital Bichat, Paris